Cadre (CDRE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 May, 2026Executive summary
Supplement corrects typographical errors in the previously filed Proxy Statement for the 2026 Annual Meeting scheduled for May 29, 2026, to be held via live webcast.
Only the footnotes to the Summary Compensation Table for fiscal year 2025 are amended; all other information and proposals remain unchanged.
Executive compensation and say-on-pay
Revised "All Other Compensation" for Mr. Kanders in 2025: $194,518 for unallocated expense reimbursement, $4,811 for life insurance, AD&D, and wellness, $13,725 for 401(k) matching.
Revised "All Other Compensation" for Mr. Williams in 2025: $13,725 for 401(k) matching, $22,253 for company-paid health care, $1,695 for life insurance, AD&D, and wellness.
Revised "All Other Compensation" for Mr. Browers in 2025: $13,725 for 401(k) matching, $22,253 for company-paid health care, $1,455 for life insurance, AD&D, and wellness.
Voting matters and shareholder proposals
No changes to proposals or board recommendations; proxies already submitted remain valid unless changed by shareholders.
Latest events from Cadre
- Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation18 May 2026 - Q1 2026 net sales up 19%, record backlog, and reaffirmed strong full-year guidance.CDRE
Q1 202615 May 2026 - Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing24 Apr 2026 - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026